Literature DB >> 19566712

Deletion of agouti-related protein blunts ethanol self-administration and binge-like drinking in mice.

M Navarro1, I Cubero, L Ko, T E Thiele.   

Abstract

The melanocortin (MC) system is composed of peptides that are cleaved from the polypeptide precursor proopiomelanocortin (POMC). Recent pharmacological and genetic evidence suggests that melanocortin receptor (MCR) signaling modulates neurobiological responses to ethanol and ethanol intake. Agouti-related protein (AgRP) is synthesized by neurons in the arcuate nucleus of the hypothalamus and is a natural antagonist of MCRs. Because central administration of the functionally active AgRP fragment AgRP-(83-132) increases ethanol intake by C57BL/6 J mice, we determined if mutant mice lacking normal production of AgRP (AgRP(-/-)) and maintained on a C57BL/6 J genetic background would show reduced self-administration of ethanol relative to littermate wild-type (AgRP(+/+)) mice. AgRP(-/-) mice showed reduced 8% (v/v) ethanol-reinforced lever-pressing behavior relative to AgRP(+/+) mice in daily 2-h sessions, but normal sucrose-, saccharin- and water-reinforced lever-pressing. Similarly, AgRP(-/-) mice showed reduced consumption of 8% ethanol in a two-bottle limited access test (2 h/day), although this effect was largely sex-dependent. Using drinking-in-the-dark (DID) procedures, AgRP(-/-) mice showed blunted binge-like drinking of 20% (v/v) ethanol which was associated with lower blood ethanol levels (85 mg/dl) relative to AgRP(+/+) mice (133 mg/dl) after 4 h of intake. AgRP(-/-) mice showed normal ethanol metabolism and did not show altered sensitivity to the sedative effects of ethanol. These observations with genetically altered mice are consistent with previous pharmacological data and suggest that endogenous AgRP signaling modulates the reinforcing properties of ethanol and binge-like ethanol drinking.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19566712      PMCID: PMC2728437          DOI: 10.1111/j.1601-183X.2009.00493.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  54 in total

1.  Characterization of the effects of acute ethanol administration on the release of beta-endorphin peptides by the rat hypothalamus.

Authors:  C Gianoulakis
Journal:  Eur J Pharmacol       Date:  1990-05-03       Impact factor: 4.432

Review 2.  The opiomelanotropinergic neuronal and endocrine systems.

Authors:  T L O'Donohue; D M Dorsa
Journal:  Peptides       Date:  1982 May-Jun       Impact factor: 3.750

3.  Neurons of the rat hypothalamus reactive with antisera against endorphins, ACTH, MSH and beta-LPH.

Authors:  B Bloch; C Bugnon; D Fellmann; D Lenys; A Gouget
Journal:  Cell Tissue Res       Date:  1979       Impact factor: 5.249

4.  Characterization of the forms of beta-endorphin and alpha-MSH in the caudal medulla of the rat and guinea pig.

Authors:  R M Dores; M Jain; H Akil
Journal:  Brain Res       Date:  1986-07-09       Impact factor: 3.252

5.  The distribution of alpha-melanocyte stimulating hormone (alpha-MSH) in the central nervous system of the rat: an immunohistochemical study. II. Lower brain stem.

Authors:  M Yamazoe; S Shiosaka; A Yagura; Y Kawai; T Shibasaki; N Ling; M Tohyama
Journal:  Peptides       Date:  1984 Jul-Aug       Impact factor: 3.750

6.  Localization of alpha-melanocyte-stimulating hormone in rat brain and pituitary.

Authors:  D Dubé; J C Lissitzky; R Leclerc; G Pelletier
Journal:  Endocrinology       Date:  1978-04       Impact factor: 4.736

7.  Studies of alpha-MSH-containing nerves in the brain.

Authors:  T L O'Donohue; D M Jacobowitz
Journal:  Prog Biochem Pharmacol       Date:  1980

8.  alpha-Melanocyte stimulating hormone: immunohistochemical identification and mapping in neurons of rat brain.

Authors:  D M Jacobowitz; T L O'Donohue
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

9.  Behavioral profile of gamma-MSH: relationship with ACTH and beta-endorphin action.

Authors:  J M van Ree; B Bohus; K M Csontos; W H Gispen; H M Greven; F P Nijkamp; F A Opmeer; G A de Rotte; T B van Wimersma Greidanus; A Witter; D de Wied
Journal:  Life Sci       Date:  1981-06-22       Impact factor: 5.037

10.  Effect of acute ethanol in vivo and in vitro on the beta-endorphin system in the rat.

Authors:  C Gianoulakis; A Barcomb
Journal:  Life Sci       Date:  1987-01-05       Impact factor: 5.037

View more
  24 in total

Review 1.  The neurobiology of binge-like ethanol drinking: evidence from rodent models.

Authors:  Gretchen M Sprow; Todd E Thiele
Journal:  Physiol Behav       Date:  2012-01-08

2.  The protective effects of the melanocortin receptor (MCR) agonist, melanotan-II (MTII), against binge-like ethanol drinking are facilitated by deletion of the MC3 receptor in mice.

Authors:  J J Olney; G M Sprow; M Navarro; T E Thiele
Journal:  Neuropeptides       Date:  2013-11-15       Impact factor: 3.286

Review 3.  "Drinking in the dark" (DID) procedures: a model of binge-like ethanol drinking in non-dependent mice.

Authors:  Todd E Thiele; Montserrat Navarro
Journal:  Alcohol       Date:  2013-10-29       Impact factor: 2.405

Review 4.  Genes and Alcohol Consumption: Studies with Mutant Mice.

Authors:  J Mayfield; M A Arends; R A Harris; Y A Blednov
Journal:  Int Rev Neurobiol       Date:  2016       Impact factor: 3.230

5.  Lateral hypothalamic melanocortin receptor signaling modulates binge-like ethanol drinking in C57BL/6J mice.

Authors:  Gretchen M Sprow; Jennifer A Rinker; Emily G Lowery-Gointa; Angela M Sparrow; Montserrat Navarro; Todd E Thiele
Journal:  Addict Biol       Date:  2015-05-15       Impact factor: 4.280

6.  Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice.

Authors:  Montserrat Navarro; Francisca Carvajal; Jose Manuel Lerma-Cabrera; Inmaculada Cubero; Mitchell J Picker; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2015-06-24       Impact factor: 3.455

Review 7.  Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use.

Authors:  Jessica R Barson; Irene Morganstern; Sarah F Leibowitz
Journal:  ILAR J       Date:  2012

Review 8.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

9.  NOP Receptor Antagonists Decrease Alcohol Drinking in the Dark in C57BL/6J Mice.

Authors:  Gloria Brunori; Michelle Weger; Jennifer Schoch; Katarzyna Targowska-Duda; Megan Barnes; Anna Maria Borruto; Linda M Rorick-Kehn; Nurulain T Zaveri; John E Pintar; Roberto Ciccocioppo; Lawrence Toll; Andrea Cippitelli
Journal:  Alcohol Clin Exp Res       Date:  2019-08-21       Impact factor: 3.455

10.  Bupropion, Alone and in Combination with Naltrexone, Blunts Binge-Like Ethanol Drinking and Intake Following Chronic Intermittent Access to Ethanol in Male C57BL/6J Mice.

Authors:  Montserrat Navarro; Kendall L Luhn; Alexey B Kampov-Polevoy; James C Garbutt; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2019-03-19       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.